131 related articles for article (PubMed ID: 21946521)
1. Taccalonolides: a microtubule stabilizer poses a new puzzle with old pieces.
Sackett DL; Fojo T
Cell Cycle; 2011 Oct; 10(19):3233-4. PubMed ID: 21946521
[No Abstract] [Full Text] [Related]
2. The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation.
Risinger AL; Riffle SM; Lopus M; Jordan MA; Wilson L; Mooberry SL
Mol Cancer; 2014 Feb; 13():41. PubMed ID: 24576146
[TBL] [Abstract][Full Text] [Related]
3. Taccalonolides: Novel microtubule stabilizers with clinical potential.
Risinger AL; Mooberry SL
Cancer Lett; 2010 May; 291(1):14-9. PubMed ID: 19880245
[TBL] [Abstract][Full Text] [Related]
4. Taccalonolide microtubule stabilizers.
Li J; Risinger AL; Mooberry SL
Bioorg Med Chem; 2014 Sep; 22(18):5091-6. PubMed ID: 24491636
[TBL] [Abstract][Full Text] [Related]
5. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
[TBL] [Abstract][Full Text] [Related]
6. Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
Risinger AL; Mooberry SL
Cell Cycle; 2011 Jul; 10(13):2162-71. PubMed ID: 21597323
[TBL] [Abstract][Full Text] [Related]
7. Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers.
Du L; Risinger AL; Yee SS; Ola ARB; Zammiello CL; Cichewicz RH; Mooberry SL
J Nat Prod; 2019 Mar; 82(3):583-588. PubMed ID: 30799622
[TBL] [Abstract][Full Text] [Related]
8. Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases.
Rohena CC; Peng J; Johnson TA; Crews P; Mooberry SL
Biochem Pharmacol; 2013 Apr; 85(8):1104-14. PubMed ID: 23399639
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
Tripathi S; Srivastava G; Sharma A
Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
[TBL] [Abstract][Full Text] [Related]
10. Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.
Li J; Risinger AL; Peng J; Chen Z; Hu L; Mooberry SL
J Am Chem Soc; 2011 Nov; 133(47):19064-7. PubMed ID: 22040100
[TBL] [Abstract][Full Text] [Related]
11. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.
Risinger AL; Jackson EM; Polin LA; Helms GL; LeBoeuf DA; Joe PA; Hopper-Borge E; Ludueña RF; Kruh GD; Mooberry SL
Cancer Res; 2008 Nov; 68(21):8881-8. PubMed ID: 18974132
[TBL] [Abstract][Full Text] [Related]
12. Taccalonolide C-6 Analogues, Including Paclitaxel Hybrids, Demonstrate Improved Microtubule Polymerizing Activities.
Risinger AL; Hastings SD; Du L
J Nat Prod; 2021 Jun; 84(6):1799-1805. PubMed ID: 34110822
[TBL] [Abstract][Full Text] [Related]
13. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
[TBL] [Abstract][Full Text] [Related]
14. Mechanical effects of EB1 on microtubules depend on GTP hydrolysis state and presence of paclitaxel.
Lopez BJ; Valentine MT
Cytoskeleton (Hoboken); 2014 Sep; 71(9):530-41. PubMed ID: 25160006
[TBL] [Abstract][Full Text] [Related]
15. CENP-E checks in microtubule-drug resistance.
Chanel-Vos C; Giannakakou P
Cell Cycle; 2010 Apr; 9(8):1456. PubMed ID: 20421712
[No Abstract] [Full Text] [Related]
16. Class III β-tubulin counteracts the ability of paclitaxel to inhibit cell migration.
Ganguly A; Yang H; Cabral F
Oncotarget; 2011 May; 2(5):368-77. PubMed ID: 21576762
[TBL] [Abstract][Full Text] [Related]
17. Taccalonolide Microtubule Stabilizers.
Yee SS; Du L; Risinger AL
Prog Chem Org Nat Prod; 2020; 112():183-206. PubMed ID: 33306174
[TBL] [Abstract][Full Text] [Related]
18. Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases.
Yang H; Cabral F
J Biol Chem; 2007 Sep; 282(37):27058-27066. PubMed ID: 17627938
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of mitotic centromere-associated Kinesin stimulates microtubule detachment and confers resistance to paclitaxel.
Ganguly A; Yang H; Cabral F
Mol Cancer Ther; 2011 Jun; 10(6):929-37. PubMed ID: 21471284
[TBL] [Abstract][Full Text] [Related]
20. Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid-induced tau phosphorylation.
Das V; Miller JH
Eur J Neurosci; 2012 Jun; 35(11):1705-17. PubMed ID: 22594877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
